Miguel Izquierdo - Concepedia

Author

Miguel Izquierdo

Also Known As

M A Izquierdo, M Izquierdo, M. A. Izquierdo, M. Izquierdo, M.A. IZQUIERDO, M.A. Izquierdo, M.A.I. Izquierdo, MIGUEL A. IZQUIERDO, Marco Antonio Izquierdo Gómez, Miguel A Izquierdo

148

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Institut Català d'Oncologia Institut Jules Bordet Breast International Group University of Amsterdam

About

Miguel Izquierdo is an author at Novartis (Switzerland) specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1.9K
2	Health Sciences	7	7	524
3	Cell Biology	3	3	523
4	Biochemistry	2	2	829
5	Arts	1	1	47

Miguel Izquierdo

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
The drug resistance-related protein LRP is the human major vault protein George L. Scheffer, Peter Wijngaard, Marcel J. Flens, Nature Medicine Protein FunctionDrug TargetBiochemistryMedicinePeptide Library	1995	617
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules George D. Demetri, Sant P. Chawla, Margaret von Mehren, Journal of Clinical Oncology	2009	524
Tissue distribution of the multidrug resistance protein. M J Flens, G J Zaman, Paul van der Valk, PubMed	1996	477
Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. M J Flens, Miguel Izquierdo, George L. Scheffer, PubMed Immunocytochemical TechniqueImmunologyImmunoeditingPathologyImmunochemical Detection	1994	275
Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded material Julio E. Diestra, George L. Scheffer, Isabel Català, The Journal of Pathology	2002	273
Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines Miguel Izquierdo, Robert H. Shoemaker, Marcel J. Flens, International Journal of Cancer Human Cancer-cell LinesBiochemistryMedicinePharmacologyCell Lines	1996	212
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Miguel Izquierdo, George L. Scheffer, M J Flens, PubMed	1996	188
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: ALTERNATIVE Stephen Johnston, Roberto Hegg, Seock‐Ah Im, Journal of Clinical Oncology	2017	166
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade Aleix Prat, Tomás Pascual, Carmine De Angelis, JNCI Journal of the National Cancer Institute	2019	163
Differential expression of the c‐<i>kit</i> proto‐oncogene in germ cell tumours Miguel Izquierdo, Paul van der Valk, J van Ark-Otte, The Journal of Pathology	1995	132

Page 1